GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) — Market Cap & Net Worth

$4.28 Billion USD · Rs395.80 Billion INR · Rank #3979

Market Cap & Net Worth: GlaxoSmithKline Pharmaceuticals Limited (GLAXO)

GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) has a market capitalization of $4.28 Billion (Rs395.80 Billion) as of May 3, 2026. Listed on the NSE stock exchange, this India-based company holds position #3979 globally and #169 in its home market, demonstrating a -5.24% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying GlaxoSmithKline Pharmaceuticals Limited's stock price Rs2336.40 by its total outstanding shares 169406034 (169.41 Million). Analyse GlaxoSmithKline Pharmaceuticals Limited cash flow conversion to see how efficiently the company converts income to cash.

GlaxoSmithKline Pharmaceuticals Limited Market Cap History: 2015 to 2026

GlaxoSmithKline Pharmaceuticals Limited's market capitalization history from 2015 to 2026. Data shows growth from $2.51 Billion to $4.28 Billion (5.21% CAGR).

Index Memberships

GlaxoSmithKline Pharmaceuticals Limited is a constituent of 4 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NIFTY 500 NIFTY500	$3.11 Trillion	0.14%	#155 of 500
NIFTY MIDCAP 150 NIFTYMIDCAP150	$695.80 Billion	0.62%	#72 of 150
NIFTY MIDSMALLCAP 400 NIFTYMIDSML400	$1.11 Trillion	0.39%	#81 of 400
NIFTY TOTAL MARKET NIFTYTOTALMKT	$3.20 Trillion	0.13%	#153 of 750

Weight: GlaxoSmithKline Pharmaceuticals Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

GlaxoSmithKline Pharmaceuticals Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how GlaxoSmithKline Pharmaceuticals Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.12x

GlaxoSmithKline Pharmaceuticals Limited's market cap is 0.12 times its annual revenue

Industry average: 1.26x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.49x

GlaxoSmithKline Pharmaceuticals Limited's market cap is 0.49 times its annual earnings

Industry average: 12.55x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$2.09 Billion	$28.38 Billion	$3.76 Billion	0.07x	0.56x
2017	$1.93 Billion	$29.08 Billion	$3.37 Billion	0.07x	0.57x
2018	$2.44 Billion	$28.71 Billion	$3.51 Billion	0.09x	0.70x
2019	$2.64 Billion	$31.28 Billion	$4.45 Billion	0.08x	0.59x
2020	$2.70 Billion	$32.24 Billion	$932.05 Million	0.08x	2.89x
2021	$2.97 Billion	$29.26 Billion	$3.58 Billion	0.10x	0.83x
2022	$2.32 Billion	$32.78 Billion	$16.95 Billion	0.07x	0.14x
2023	$3.42 Billion	$32.52 Billion	$6.11 Billion	0.11x	0.56x
2024	$4.13 Billion	$34.54 Billion	$5.90 Billion	0.12x	0.70x
2025	$4.53 Billion	$37.49 Billion	$9.28 Billion	0.12x	0.49x

Competitor Companies of GLAXO by Market Capitalization

Companies near GlaxoSmithKline Pharmaceuticals Limited in the global market cap rankings as of May 3, 2026.

Key companies related to GlaxoSmithKline Pharmaceuticals Limited by market ranking:

Eli Lilly and Company (NYSE:LLY): Ranked #16 globally with a market cap of $862.20 Billion USD.
Eli Lilly and Company (SA:LILY34): Ranked #17 globally with a market cap of $853.51 Billion USD ( R$4.35 Trillion BRL).
Johnson & Johnson (NYSE:JNJ): Ranked #23 globally with a market cap of $547.37 Billion USD.
AbbVie Inc (NYSE:ABBV): Ranked #37 globally with a market cap of $365.30 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#16	Eli Lilly and Company	NYSE:LLY	$862.20 Billion	$963.33
#17	Eli Lilly and Company	SA:LILY34	$853.51 Billion	R$153.70
#23	Johnson & Johnson	NYSE:JNJ	$547.37 Billion	$227.19
#37	AbbVie Inc	NYSE:ABBV	$365.30 Billion	$206.60

GlaxoSmithKline Pharmaceuticals Limited Historical Marketcap From 2015 to 2026

Between 2015 and today, GlaxoSmithKline Pharmaceuticals Limited's market cap moved from $2.51 Billion to $ 4.28 Billion, with a yearly change of 5.21%.

Year	Market Cap	Change (%)
2026	Rs4.28 Billion	-5.55%
2025	Rs4.53 Billion	+9.85%
2024	Rs4.13 Billion	+20.67%
2023	Rs3.42 Billion	+47.24%
2022	Rs2.32 Billion	-21.90%
2021	Rs2.97 Billion	+10.27%
2020	Rs2.70 Billion	+2.17%
2019	Rs2.64 Billion	+8.12%
2018	Rs2.44 Billion	+26.37%
2017	Rs1.93 Billion	-7.74%
2016	Rs2.09 Billion	-16.44%
2015	Rs2.51 Billion	--

End of Day Market Cap According to Different Sources

On May 3rd, 2026 the market cap of GlaxoSmithKline Pharmaceuticals Limited was reported to be:

Source	Market Cap
Yahoo Finance	$4.28 Billion USD
MoneyControl	$4.28 Billion USD
MarketWatch	$4.28 Billion USD
marketcap.company	$4.28 Billion USD
Reuters	$4.28 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About GlaxoSmithKline Pharmaceuticals Limited

NSE:GLAXO India Drug Manufacturers - General

Market Cap

$4.28 Billion

Rs395.80 Billion INR

Market Cap Rank

#3979 Global

#169 in India

Share Price

Rs2336.40

Change (1 day)

-1.28%

52-Week Range

Rs2259.50 - Rs3466.20

All Time High

Rs3466.20